Estimates of the global cost of coccidiosis in poultry vary widely, but most place the figure in the tens of billions of U.S. dollars. Coccidiosis is characterized by symptoms such as diarrhea, intestinal lesions, morbidity, and mortality, along with decreased weight gain and feed efficiency. The intestinal damage caused by the disease can lead to secondary issues such as necrotic enteritis, which has become more prevalent as poultry producers reduce antibiotic use. The majority of losses stem from reduced production due to subclinical coccidiosis. The lack of overt disease emphasizes the importance of vigilance and proactive management systems.
To combat the impact of coccidiosis in poultry, producers rely on a range of methods, each offering unique benefits and presenting specific limitations. Traditional control methods include the use of vaccines, ionophores, and chemical coccidostats. However, natural alternatives for managing coccidiosis have been developed through the years, including the use of phytogenic compounds.
A Sustainable Natural Alternative
Phylox® (available from Amlan International in select international markets), a natural feed additive featuring a select blend of bioactive phytochemicals was researched to determine its effects on broilers challenged with multiple species of Eimeria. Phylox is designed to interrupt the complex Eimeria lifecycle at several key points, preventing damage to the host and reducing the risk of growing resistance. It works by compromising the sporozoites’ cell membrane, inhibiting oocyst sporulation, enhancing anticoccidial immunity, and supplying essential energy to the intestinal cells. By targeting all three stages of the coccidia lifecycle, Phylox helps protect intestinal integrity and support overall bird health.
Research shows that Phylox decreases the effects of coccidiosis on gut health and improves bird performance. Two experiments that lasted 28 days each were used to study its effects on young broilers during an Eimeria challenge. Both studies used a multi-species coccidia challenge that included giving an oral dose of E. maxima (50,000 oocysts), E. acervulina (100,000 oocysts), and E. tenella (75,000 oocysts) to each bird on the 14th day of the experiment. Six days post-challenge five birds per pen (eight pens per treatment) were euthanized so that intestines could be inspected for coccidial lesions. The Johnson and Reid (1970) scoring method was used to assess the severity of intestinal lesions caused by coccidiosis, with a score from 0 (no visible lesions) to 4 (severe, widespread lesions). No coccidia vaccine or medication was used in the first study, which evaluated the effect of Phylox on both unchallenged and challenged broilers. The second study was conducted to compare Phylox to drugs currently used to control coccidiosis in the field.
Feeding Phylox improved gut health in broilers challenged with multiple Eimeria species. This was evidenced by lower coccidia lesion scores in birds fed Phylox compared to untreated, challenged birds (Study 1), with scores decreasing from 2.43 to 1.85. Lower lesion scores, indicating improved gut health, are expected to result in better feed efficiency. Feeding Phylox to birds challenged with multiple Eimeria species improved feed conversion, both during the critical period following the challenge and overall. Additionally, no negative effects were observed in unchallenged birds fed Phylox.
In Study Two, feeding Phylox, salinomycin, or Nicarbazin equally reduced lesion scores compared to challenged but untreated birds. The resulting improvement in gut health led to improved feed conversion ratios for all treatments. Each of the three coccidiosis treatments produced similar results, with improvement in feed conversion observed both during the post-challenge period and throughout the overall experimental period. This research demonstrates that feeding Phylox to Eimeria-challenged broilers mitigated the effects of coccidiosis, with outcomes comparable to those of commonly used treatments.
Immune Function
The gut of any animal faces constant challenges. Broilers continuously ingest bacteria, parasites, toxins, and other harmful substances along with their feed and water. The intestinal wall acts as a crucial barrier, preventing these pathogens from entering the body. This is why the majority of a chicken’s immune tissue is located in the gastrointestinal tract.
A third experiment examined the effects of coccidia and Phylox on immunity and gut microbiota. The research showed that Phylox helped preserve immune homeostasis by enhancing the anticoccidial immune response during coccidial challenge. Specifically, Phylox preserved the function of protective mucosal immunity by promoting a non-terminally differentiated helper T-cell subset (CD8-CD28+). This helps ensure a competent T-cell response during pathogen challenges, such as the Eimeria challenge used in this experiment.
Additionally, Phylox reduced Eimeria challenge-associated upregulation of cecal IL-10. IL-10 is an anti-inflammatory cytokine with potent immunosuppressive effects. Intracellular parasites like coccidia can use the immunosuppressive properties of IL-10 to help them survive in a hostile environment. When coccidia causes an increase in IL-10 during a challenge, as seen in this experiment, it results in a decreased immune response just when the animal needs the immune response to help fight the disease. Phylox fed broilers showed suppression of IL-10 during the coccidia infection, allowing a proper and effective immune response to occur. This was shown by decreased cecal IL-10 mRNA when Phylox was fed.
Summary
To mitigate losses associated with coccidiosis in poultry, innovative solutions are essential to complement existing vaccines and drugs. Producers require new, consumer-accepted alternatives to effectively manage coccidiosis on their farms. Phylox serves as a valuable addition to the available tools, helping to address this persistent challenge and support poultry health and productivity. To learn more about Phylox, or to begin a field trial, contact your local Amlan representative here.
